Regular Article
Nasal Cytochrome P450 2A: Identification, Regional Localization, and Metabolic Activity toward Hexamethylphosphoramide, a Known Nasal Carcinogen

https://doi.org/10.1006/taap.1996.7975Get rights and content

Abstract

Two members of the cytochrome P450 2A subfamily, CYP2A10 and 2A11, are abundant nasal enzymes previously characterized in rabbit olfactory microsomes. Rabbit CYP2A is active toward a number of nasal toxicants, including the rat nasal procarcinogen hexamethylphosphoramide (HMPA). While P450s immunochemically related to the rabbit CYP2As have been detected in rat and human nasal mucosa, confirmation of these enzymes as members of the CYP2A subfamily and efforts to characterize their ability to bioactivate toxicants have been limited. In the present study, the regional distribution and cell-specific expression of CYP2A in the rat nasal cavity were examined using an antibody to rabbit CYP2A10/11. In sections of the anterior nose, immunoreactive CYP2A was present in ciliated cells of the nasal respiratory epithelium and cuboidal epithelial cells of the nasal transitional epithelium, but was absent in squamous epithelial cells. The most intense immunostaining was observed in the posterior nose. Olfactory sustentacular cells and Bowman's gland cells in sections posterior to the nasal papilla stained most intensely. Western blot analysis revealed that anti-CYP2A10/11 recognized a sharp band of approximately 50 kDa in nasal respiratory and olfactory microsomes, supporting the premise that the antibody is reacting with a cytochrome P450 enzyme. The nasal expression of CYP2A6 mRNA—a member of the human CYP2A subfamily having a high degree of homology to rabbit 2A10 and 2A11—was examined in human surgical patients. Middle turbinectomy tissues—largely composed of nasal respiratory epithelia—from 11 patients were analyzed for the presence of CYP2A6 using reverse transcription–polymerase chain reaction (RT–PCR). Identification of CYP2A6 was confirmed by DNA sequencing of RT–PCR products. CYP2A6 mRNA was detected in all of the human samples analyzed. In additional experiments, human CYP2A6 metabolized HMPA to formaldehyde, suggesting that this compound might cause nasal toxicity in humans. The identification of CYP2A cytochromes in rat and human nasal tissues may have important implications for risk assessment of inhaled xenobiotics.

References (0)

Cited by (63)

  • Nasal accumulation and metabolism of Δ<sup>9</sup>-tetrahydrocannabinol following aerosol (‘vaping’) administration in an adolescent rat model

    2023, Pharmacological Research
    Citation Excerpt :

    This finding is novel, but not completely unexpected. Previous research showed that rat nasal mucosa and lungs express various cytochrome P450 isoforms [31,32] which catalyze this reaction [33-35]. THC biotransformation in nasal mucosa is likely to be functionally relevant because the maximal concentrations reached by 11-OH-THC in the nasal cavity were sizeable (double-digit micromolar) and approximately 80 times higher than those found in plasma.

  • Advanced formulations for intranasal delivery of biologics

    2018, International Journal of Pharmaceutics
    Citation Excerpt :

    After the administration, the initial glucose blood concentration was decreased by 40% for 4–5 h (Wu et al., 2007). Although there are only few reports available on human nasal metabolism, these observations strongly suggest the presence of significant metabolic activity on human nasal mucosa (Sarkar, 1992). The degree of degenerative enzymes is comparable low in reference to the gastro-intestinal tract, however as inactivation of therapeutics can quickly take place, they might dramatically decrease systemic bioavailability.

  • Distribution of α-asarone in brain following three different routes of administration in rats

    2014, European Journal of Pharmaceutical Sciences
    Citation Excerpt :

    Intranasal administration can avoid the side effects caused by the first-pass metabolism when the drug is administered orally. Although drugs might not escape entirely from metabolic effects because of enzymes such as cytochrome P450 enzymes in the intranasal environment (Thornton-Manning et al., 1997; Zhang et al., 2005), reducing this effect is very important for drugs that are strongly impaired by the significant first pass metabolism, such as verapamil HCl (Abdel Mouez et al., 2014), rivastigmine (Yang et al., 2013), and zolmitriptan (Vyas et al., 2005). The particle-size distribution of the α-asarone powder was very heterogeneous, with both large and small particles, and it is well known that particles with diameters between 2 and 5 μm can deposit in the lungs.

  • Bioactivation of coumarin in rat olfactory mucosal microsomes: Detection of protein covalent binding and identification of reactive intermediates through analysis of glutathione adducts

    2009, Chemico-Biological Interactions
    Citation Excerpt :

    Forming a barrier between the external environment of the nasal cavity and the systemic circulation and adjacent brain tissue, the mammalian olfactory mucosa (OM) is unique relative to many other tissues in drug metabolism and toxicity perspectives, due to the presence of tissue-predominant (e.g., human CYP2A13, rat CYP2A3, mouse CYP2A5) and tissue-specific (e.g., rat and mouse CYP2G1) cytochrome P450s (CYPs) at a high expression level (pmol/mg protein) (reviewed in [1–3]). Teamed with high contents of NADPH-cytochrome P450 reductase (CPR) in the tissue, OM displays a substantial metabolic capacity toward endogenous steroids (e.g. testosterone and progesterone) [4,5] and a growing list of inhaled or systemically exposed olfactory toxicants and procarcinogens, such as 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 2,6-dichlorobenzonitrile, acetaminophen (AP), coumarin, hexamethylphosphoramide and 2,6-diclorophenyl methylsulfone [2,6–11]. The high metabolic turnover rate in OM is generally believed to maintain homeostasis of the chemosensory tissue and protect the adjacent brain tissue from environmental insults [12].

View all citing articles on Scopus
1

To whom correspondence should be addressed. Fax: (505) 845-1198.

2

Present address: Dept. of Pathology, Michigan State University, College of Veterinary Medicine A46, East Lansing, MI 48824.

View full text